Top Buy
| Security | Buy | Sell | Buy (1M) | Sell (1M) ▲ | Price | Target price | Potential |
|---|---|---|---|---|---|---|---|
| Lexicon Pharmaceuticals Inc. | 4 | 0 | 2 | 0 | €1.57 | €7.66 | 386.372% |
| Exelixis Inc. | 18 | 0 | 0 | 0 | €20.95 | €26.01 | 24.136% |
| Innoviva Inc. | 4 | 0 | 1 | 0 | €15.20 | €30.00 | 97.368% |
| Cytokinetics Inc. | 34 | 1 | 4 | 0 | €48.40 | €83.21 | 71.911% |
| Arrowhead Pharmaceuticals Inc. | 20 | 2 | 6 | 0 | €24.24 | €54.74 | 125.842% |
| Halozyme Therapeutics Inc. | 20 | 0 | 5 | 0 | €48.90 | €52.75 | 7.869% |
| Brainstorm Cell | 1 | 0 | 0 | 0 | €0.36 | - | - |
| Vanda Pharmaceuticals | 4 | 0 | 0 | 0 | €5.30 | €5.00 | -5.660% |
| Madrigal Pharmaceuticals inc. | 3 | 0 | 0 | 0 | €261.30 | €315.00 | 20.551% |
| Amicus Therapeutics Inc. | 7 | 0 | 1 | 0 | €9.15 | €17.64 | 92.762% |
| Heron Therapeutics Inc. | 12 | 1 | 1 | 0 | €3.18 | €4.60 | 44.595% |
| Catalyst Pharmaceutical Partners Inc | 14 | 0 | 3 | 0 | €14.05 | €24.13 | 71.767% |
| Celldex Therapeutics | 15 | 1 | 4 | 0 | €34.60 | €58.01 | 67.661% |
| EyePoint Pharmaceuticals Inc. | 22 | 1 | 4 | 0 | €8.12 | €27.83 | 242.831% |
| Omeros Corp. | 2 | 4 | 0 | 0 | €3.62 | - | - |
| Avid Bioservices Inc | 2 | 0 | 0 | 0 | €6.50 | €8.75 | 34.615% |
| Vericel Corp. | 1 | 0 | 0 | 0 | €43.40 | - | - |
| Insmed Inc. | 34 | 0 | 15 | 0 | €62.50 | €67.14 | 7.424% |
| Codexis Inc. | 7 | 2 | 2 | 0 | €2.89 | €8.36 | 189.508% |
| Verastem Inc. | 11 | 0 | 2 | 0 | €2.78 | €19.20 | 590.644% |
| Puma Biotechnology Inc. | 2 | 0 | 1 | 0 | €3.02 | €10.00 | 230.907% |
| Rockwell Medical Inc. | 1 | 0 | 0 | 0 | €1.64 | €3.00 | 83.486% |
| Agios Pharmaceuticals Inc. | 8 | 0 | 2 | 0 | €40.80 | €43.87 | 7.522% |
| MacroGenics Inc. | 13 | 0 | 0 | 0 | €3.82 | €12.42 | 225.595% |
| TG Therapeutics Inc. | 22 | 4 | 0 | 0 | €16.62 | €28.06 | 68.880% |